Evidence map›Paper›PMID 25562496›Full record

ArticleAIDS (London, England)2015

Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Kathryn Rough, Katherine Tassiopoulos, Deborah Kacanek, Raymond Griner, Ram Yogev, Kenneth C Rich, George R Seage, Pediatric HIVAIDS Cohort Study

Registry-linked trialAbstract read
In one paragraph

Article in AIDS (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01310023 (Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01310023 completednot on this map

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

TypeobservationalSponsorHarvard School of Public Health (HSPH)Ran2007 to 2025Enrolled5,169ConditionsAntiretroviral Toxicity
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living With Human Immunodeficiency Virus in the United States (2005-2016).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kathryn RoughaDepartment of Epidemiology bCenter for Biostatistics and AIDS Research, Harvard School of Public Health, Boston, Massachusetts, USA cDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill School of Medicine, Montreal, Quebec, Canada dDepartment of Pediatrics, Lurie Children's Hospital eDepartment of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA.
Katherine Tassiopoulos
Deborah Kacanek
Raymond Griner
Ram Yogev
Kenneth C Rich
George R Seage
Pediatric HIVAIDS Cohort Study
Cancer Research And Biostatistics · USLurie Children's Hospital · USUniversity of Illinois Chicago · US

Funding

PHACS - Data and Operations CenterU01HD052102 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLIAMS, PAIGE L · 2005 to 2019
$242.7M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Pediatric HIV/AIDS Cohort Study (PHACS): Understanding Maternal HIV Disease through Pregnancy and the Postpartum Period and its Role in Child Health OutcomesU01HD052104 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI VAN DYKE, RUSSELL B. · 2005 to 2019
$15.7M
NCATS NIH HHS UL1 TR001082NICHD NIH HHS 3 U01 HD052102-05S1NICHD NIH HHS 3 U01HD052102-06S3NICHD NIH HHS 3U01HD052104-06S1NICHD NIH HHS HD052102NICHD NIH HHS HD052104NICHD NIH HHS U01 HD052102NICHD NIH HHS U01 HD052104
6 · The paper itself

Abstract

objectiveWe aimed to describe temporal changes in substance use among HIV-infected pregnant women in the United States from 1990 to 2012.

designData came from two prospective cohort studies (Women and Infants Transmission Study and Surveillance Monitoring for Antiretroviral Therapy Toxicities Study).

methodsWomen were classified as using a substance during pregnancy if they self-reported use or had a positive biological sample. To account for correlation between repeated pregnancies by the same woman, generalized estimating equation models were used to test for temporal trends and evaluate predictors of substance use.

resultsOver the 23-year period, substance use among the 5451 HIV-infected pregnant women sharply declined; 82% of women reported substance use during pregnancy in 1990, compared with 23% in 2012. Use of each substance decreased significantly (P < 0.001 for each substance) in an approximately linear fashion, until reaching a plateau in 2006. Multivariable models showed substance use was inversely associated with receiving antiretroviral therapy. Among the subset of 824 women with multiple pregnancies under observation, women who used a substance in their previous pregnancy were at elevated risk of substance use during their next pregnancy (risk ratio, 5.71; 95% confidence interval, 4.63-7.05).

conclusionA substantial decrease in substance use during pregnancy was observed between 1990 and 2012 in two large US cohorts of HIV-infected women. Substance use prevalence in these cohorts became similar to that of pregnant women in the general US population by the mid-2000s, suggesting that the observed decrease may be due to an epidemiological transition of the HIV epidemic among women in the United States.

Indexed as

AdolescentAdultFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMiddle AgedPregnancyPregnancy Complications, InfectiousPrevalenceProspective StudiesSubstance-Related DisordersUnited StatesYoung Adult

Identifiers

PMID25562496
PMCPMC4285630
OpenAlexW1972086498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.